Growth Equity Opportunities 17, LLC → VistaGen Therapeutics, Inc. VTGN

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

3 transactions

3 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 3.44

1,410,489 shares short · +9.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-07	Tressler Nick B.	officer	Award	75,000	$0.54	$40K
2026-04-07	Singh Shawn	director, officer	Award	3,732	$0.54	$2K
2026-04-07	Prince Joshua S.	officer	Award	18,752	$0.54	$10K

Other 13D/G Filings on VistaGen Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2021-04-29	SC	Growth Equity Opportunities 17, LLC	—	—	view →
2018-01-09	SC	SABBY MANAGEMENT, LLC	—	—	view →

Other Filings by Growth Equity Opportunities 17, LLC

Filed	Form	Issuer	Stake	Shares
2023-05-02	SC	Satsuma Pharmaceuticals, Inc.	—	—	view →
2021-04-29	SC	VistaGen Therapeutics, Inc. VTGN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →